- South Korea
- /
- Chemicals
- /
- KOSDAQ:A348370
3 KRX Growth Companies With Up To 38% Insider Ownership
Reviewed by Simply Wall St
Over the last 7 days, the South Korean market has risen 2.2%, while its performance over the past year has been flat. In this environment where earnings are forecast to grow by 29% annually, identifying growth companies with significant insider ownership can provide valuable insights into potential investment opportunities.
Top 10 Growth Companies With High Insider Ownership In South Korea
Name | Insider Ownership | Earnings Growth |
People & Technology (KOSDAQ:A137400) | 16.5% | 35.6% |
Seojin SystemLtd (KOSDAQ:A178320) | 30.5% | 52.1% |
Bioneer (KOSDAQ:A064550) | 17.5% | 97.6% |
ALTEOGEN (KOSDAQ:A196170) | 26.6% | 99.5% |
Park Systems (KOSDAQ:A140860) | 33% | 35.7% |
Vuno (KOSDAQ:A338220) | 19.5% | 110.9% |
Devsisters (KOSDAQ:A194480) | 26.2% | 63% |
HANA Micron (KOSDAQ:A067310) | 18.3% | 100.3% |
INTEKPLUS (KOSDAQ:A064290) | 16.3% | 96.7% |
Techwing (KOSDAQ:A089030) | 18.7% | 83.6% |
We'll examine a selection from our screener results.
ALTEOGEN (KOSDAQ:A196170)
Simply Wall St Growth Rating: ★★★★★★
Overview: ALTEOGEN Inc. is a biotechnology company specializing in long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩16.97 trillion.
Operations: The company's revenue primarily comes from its biotechnology segment, totaling ₩90.79 billion.
Insider Ownership: 26.6%
ALTEOGEN, a South Korean growth company with high insider ownership, recently received MFDS approval for Tergase®, a recombinant hyaluronidase. This milestone supports its transition to a commercial-stage company. The stock is trading at 75.2% below fair value and is forecast to become profitable in three years with revenues growing at 64.2% per year, significantly outpacing the market average. Despite recent shareholder dilution and share price volatility, earnings are expected to grow by 99.46% annually with very high future return on equity (66.3%).
- Take a closer look at ALTEOGEN's potential here in our earnings growth report.
- Our valuation report here indicates ALTEOGEN may be overvalued.
Enchem (KOSDAQ:A348370)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩3.81 billion.
Operations: Enchem's primary revenue segment is Electronic Components & Parts, generating ₩348.75 million.
Insider Ownership: 19.4%
Enchem, a South Korean company with significant insider ownership, is forecast to become profitable within the next three years, showing annual earnings growth of 155.2%. Revenue is expected to grow at 63% per year, substantially outpacing the market average of 10.1%. However, shareholders have experienced dilution over the past year and the stock has displayed high volatility in recent months. No substantial insider trading activity has been recorded in the last three months.
- Navigate through the intricacies of Enchem with our comprehensive analyst estimates report here.
- Our comprehensive valuation report raises the possibility that Enchem is priced higher than what may be justified by its financials.
Doosan (KOSE:A000150)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Doosan Corporation operates in heavy industry, machinery manufacturing, and apartment construction across South Korea, the United States, Asia, the Middle East, Europe, and internationally with a market cap of ₩2.48 trillion.
Operations: The company's revenue segments include Doosan Bobcat (₩9.31 billion), Doosan Energy (₩8.25 billion), Electronic BG (₩855.42 million), Doosan Fuel Cell (₩279.99 million), and Digital Innovation BU (₩286.29 million).
Insider Ownership: 38.9%
Doosan, with substantial insider ownership, is expected to become profitable within three years, showing annual earnings growth of 65.51%. However, its revenue growth forecast of 3.7% per year lags behind the market average of 10.1%. The stock trades at a significant discount to its estimated fair value but has shown high volatility recently. No notable insider trading activity has been recorded in the past three months.
- Get an in-depth perspective on Doosan's performance by reading our analyst estimates report here.
- According our valuation report, there's an indication that Doosan's share price might be on the cheaper side.
Key Takeaways
- Delve into our full catalog of 78 Fast Growing KRX Companies With High Insider Ownership here.
- Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Enchem might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About KOSDAQ:A348370
Enchem
Manufactures and sells electrolytes and additives for secondary batteries and EDLC.
High growth potential with adequate balance sheet.